Heart Failure
RSSArticles
-
Interatrial Shunt Device for Heart Failure Disappoints
Placement of an interatrial shunt device in patients with heart failure with preserved or mildly reduced ejection fraction did not lower the rate of heart failure events or improve health status.
-
Treatment Indication for Diabetes Drug Expanded to Include Heart Failure
FDA approves empagliflozin to help lower risk of hospitalization, death among heart failure patients.
-
Screen Older Heart Failure Patients for Transthyretin Cardiac Amyloidosis
A screening study of heart failure patients ≥ age 60 years, left ventricular ejection fraction ≥ 40%, and left ventricle wall thickness ≥ 12 mm revealed 6.3% prevalence of transthyretin cardiac amyloidosis, a highly treatable disease.
-
USPSTF Weighs in on Key Cardiology Topics
Should clinicians screen asymptomatic older patients for atrial fibrillation? What is the best treatment course for patients without cardiovascular disease risk?
-
Should the Cath Lab Be Activated?
How should one interpret the ECG in the figure? Should the cardiac cath lab be activated on the basis of this ECG?
-
Heart Health and Cognitive Decline: Who Fares Better?
More middle-age men might be living with various cardiovascular risk factors and diseases, but the associated negative effects on cognition could be worse for women of the same age with the same conditions.
-
Jugular Venous Pressure by Bedside Ultrasound
Using a handheld point-of-care ultrasound device to estimate right atrial pressure from images of the jugular vein resulted in a higher imaging success rate vs. visual inspection and a reasonably accurate estimation, especially in those with elevated right atrial pressures.
-
Beyond COVID, Other Key Research Breakthroughs Occurred in 2021
American Heart Association highlights progress on diabetes treatment, stroke prevention, and anti-clotting medication.
-
Role of Beta-Blockers in Heart Failure with Preserved Ejection Fraction
Discontinuation of beta-blockers in heart failure with preserved ejection fraction patients significantly improved quality of life scores and expanded exercise capacity.
-
Slow, Steady, and Synchronized Wins the Race
In patients with atrial fibrillation and heart failure, definitive rate control via atrioventricular junction ablation and biventricular pacing resulted in a significant reduction in all-cause mortality vs. pharmacologic rate control.